EAST BRUNSWICK, N.J., Jan. 8, 2016 /PRNewswire-iReach/ -- Casper Pharma LLC, a New Jersey corporation and affiliate of Citron Pharma LLC, announces the launch of commercial operations in the US with the acquisition of four brand pharmaceutical products from Shionogi US representing a combined addressable market size of over $196 million; Triglide® Tablets, Robinul® and Robinul Forte® Tablets, Furadantin® Suspension and Fexmid® Tablets. The combination of the launch of commercial operations with the acquisition of these cornerstone products places Casper Pharma on a fast track for revenue growth in 2016.
Logo - http://photos.prnewswire.com/prnh/20160107/320196LOGO
"The launch of Casper Pharma is an outgrowth of our success at Citron Pharma and an evolution of our strategy to create an exceptional pharmaceutical company," said Vimal Kavuru, President and CEO. "Our experienced management team is committed to maintaining a highly efficient operation across the organization, creating a solid foundation for long-term growth."
Commenting on the launch, Casper Pharma Executive Vice President, Ira Baeringer, stated: "We are anchoring the launch of Casper Pharma to the acquisition of four well-known brand franchises in the US market. The foundation of growth at Casper Pharma is a strategically focused business development initiative, focused on valued heritage brands in diverse market segments. By all measures, we are off to a strong start in 2016". "The Shionogi portfolio is the first of several planned launches at Casper Pharma this year. Six additional brands, previously acquired from Pfizer, are scheduled to be reintroduced to the market later in 2016. This will further position Casper Pharma as one of the fastest growing brand companies."
Ashok Mayya, Casper Pharma COO states, "Casper Pharma is headquartered at Two Tower Center in East Brunswick, NJ. This prominent location in the midst of a concentrated Pharma corridor provides us the flexibility, and footprint to continue to scale operations as we grow and add the talent and expertise required for continued success."
About Casper Pharma LLC
Casper Pharma LLC is a recently launched branded pharmaceutical company engaged in the acquisition, sales and marketing of branded pharmaceutical products for the U.S. prescription drug market. Casper Pharma's products cover a number of therapeutic categories, including but not limited to: cardiovascular, gastrointestinal, urological, and pain management, where there is a sustained medical need.
For more information on Casper Pharma LLC:
Customer Service:
Phone: 844-5-CASPER (844-522-7737), Email: cs@casperpharma.com, Fax: 732-246-2175, Hours: 8:00am-7:00pm, CST Monday- Friday
Media Contact:Ira Baeringer, Casper Pharma, 732-917-6069, ibaeringer@casperpharma.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Casper Pharma LLC
